2715 related articles for article (PubMed ID: 7656781)
1. [The antitumor activities of gnidimacrin isolated from Stellera chamaejasme L].
Feng W; Tetsuro I; Mitsuzi Y
Zhonghua Zhong Liu Za Zhi; 1995 Jan; 17(1):24-6. PubMed ID: 7656781
[TBL] [Abstract][Full Text] [Related]
2. Antitumor activity of daphnane-type diterpene gnidimacrin isolated from Stellera chamaejasme L.
Yoshida M; Feng W; Saijo N; Ikekawa T
Int J Cancer; 1996 Apr; 66(2):268-73. PubMed ID: 8603823
[TBL] [Abstract][Full Text] [Related]
3. [The antitumor effects of total-flavonoid from Stellera chamaejasmel].
Wang M; Jia ZP; Ma J; Wang B
Zhongguo Zhong Yao Za Zhi; 2005 Apr; 30(8):603-6. PubMed ID: 16011286
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of a novel podophyllotoxin derivative (TOP-53) against lung cancer and lung metastatic cancer.
Utsugi T; Shibata J; Sugimoto Y; Aoyagi K; Wierzba K; Kobunai T; Terada T; Oh-hara T; Tsuruo T; Yamada Y
Cancer Res; 1996 Jun; 56(12):2809-14. PubMed ID: 8665518
[TBL] [Abstract][Full Text] [Related]
5. [The antitumor activities of the extracts from Stellera chamaejasmel L. in vitro by means of systematic solvent extraction].
Wang B; Wang R; Jia Z; Fan J; Ma J; Zhang R
Zhong Yao Cai; 2004 May; 27(5):355-7. PubMed ID: 15376391
[TBL] [Abstract][Full Text] [Related]
6. Hypoestoxide, a natural nonmutagenic diterpenoid with antiangiogenic and antitumor activity: possible mechanisms of action.
Ojo-Amaize EA; Nchekwube EJ; Cottam HB; Bai R; Verdier-Pinard P; Kakkanaiah VN; Varner JA; Leoni L; Okogun JI; Adesomoju AA; Oyemade OA; Hamel E
Cancer Res; 2002 Jul; 62(14):4007-14. PubMed ID: 12124334
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of antitumor action of PKC activator, gnidimacrin.
Yoshida M; Yokokura H; Hidaka H; Ikekawa T; Saijo N
Int J Cancer; 1998 Jul; 77(2):243-50. PubMed ID: 9650560
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic activity of trewiasine in 4 human cancer cell lines and 5 murine tumors.
Yue XF; Han JX; Shen ZM; Yang WY; Lu LJ; Li BJ; Wang C; Xu XK
Zhongguo Yao Li Xue Bao; 1992 May; 13(3):252-5. PubMed ID: 1442109
[TBL] [Abstract][Full Text] [Related]
9. Involvement of PKC betaII in anti-proliferating action of a new antitumor compound gnidimacrin.
Yoshida M; Heike Y; Ohno S; Ikekawa T; Wakasugi H
Int J Cancer; 2003 Jul; 105(5):601-6. PubMed ID: 12740906
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of novel ailanthone derivatives in vitro and in vivo.
Kato T; Suzumura Y; Fukushima M; Honda T; Nakanishi T; Noguchi T
Anticancer Res; 1988; 8(4):573-9. PubMed ID: 3178149
[TBL] [Abstract][Full Text] [Related]
11. PNAS-4, a novel pro-apoptotic gene, can potentiate antineoplastic effects of cisplatin.
Yuan Z; Yan F; Wang YS; Liu HY; Gou LT; Zhao XY; Lai ST; Deng HX; Li J; Ding ZY; Xiong SQ; Kan B; Mao YQ; Chen LJ; Wei YQ; Zhao X
Cancer Chemother Pharmacol; 2009 Dec; 65(1):13-25. PubMed ID: 19387645
[TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts.
Gourdeau H; Genne P; Kadhim S; Bibeau L; Duchamp O; Ouellet F; deMuys JM; Bouffard DY; Attardo G
Cancer Chemother Pharmacol; 2002 Dec; 50(6):490-6. PubMed ID: 12451476
[TBL] [Abstract][Full Text] [Related]
13. Antiangiogenic effects of the novel camptothecin ST1481 (gimatecan) in human tumor xenografts.
Petrangolini G; Pratesi G; De Cesare M; Supino R; Pisano C; Marcellini M; Giordano V; Laccabue D; Lanzi C; Zunino F
Mol Cancer Res; 2003 Oct; 1(12):863-70. PubMed ID: 14573787
[TBL] [Abstract][Full Text] [Related]
14. In vivo tumor growth inhibition produced by a novel sulfonamide, E7010, against rodent and human tumors.
Koyanagi N; Nagasu T; Fujita F; Watanabe T; Tsukahara K; Funahashi Y; Fujita M; Taguchi T; Yoshino H; Kitoh K
Cancer Res; 1994 Apr; 54(7):1702-6. PubMed ID: 8137285
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the pharmacological profile of an olivacine derivative and a potential prodrug.
Kraus-Berthier L; Guilbaud N; Léonce S; Parker T; Genissel P; Guillonneau C; Goldstein S; Atassi G; Pierré A
Cancer Chemother Pharmacol; 2002 Aug; 50(2):95-103. PubMed ID: 12172972
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapeutic potential of two gallic acid derivative compounds from leaves of Casearia sylvestris Sw (Flacourtiaceae).
Da Silva SL; Chaar Jda S; Yano T
Eur J Pharmacol; 2009 Apr; 608(1-3):76-83. PubMed ID: 19222998
[TBL] [Abstract][Full Text] [Related]
17. Antitumor and antimetastatic activities of 4-hydroxyderricin isolated from Angelica keiskei roots.
Kimura Y; Taniguchi M; Baba K
Planta Med; 2004 Mar; 70(3):211-9. PubMed ID: 15114497
[TBL] [Abstract][Full Text] [Related]
18. Comparative antitumor activities of halichondrins and vinblastine against human tumor xenografts.
Fodstad O; Breistøl K; Pettit GR; Shoemaker RH; Boyd MR
J Exp Ther Oncol; 1996 Mar; 1(2):119-25. PubMed ID: 9414395
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of imidazothioxanthones in murine and human tumor models in vitro and in vivo.
Varvaresou A; Iakovou K; Gikas E; Fichtner I; Fiebig HH; Kelland LR; Double JA; Bibby MC; Hendriks HR
Anticancer Res; 2004; 24(2B):907-19. PubMed ID: 15161044
[TBL] [Abstract][Full Text] [Related]
20. [Studies on the anticancer effect of howiinol A, a new compound isolated from Goniothalamus howii].
He J; Ye Y; Xu C
Yao Xue Xue Bao; 1998 Jul; 33(7):493-7. PubMed ID: 12016881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
